Palisade Asset Management, LLC Amgen Inc Transaction History

Palisade Asset Management, LLC

$1.02 Billion
Q3 2024

A detailed history of Palisade Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Palisade Asset Management, LLC holds 71,948 shares of AMGN stock, worth $21.2 Million. This represents 2.28% of its overall portfolio holdings.

Number of Shares

71,948

Previous 72,282 0.46%

Holding current value

$21.2 Million

Previous $22.6 Million 2.65%

% of portfolio

2.28%

Previous 2.34%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $103,332 - $112,684	-334 Reduced 0.46%	71,948 $23.2 Million
Q2 2024 Aug 01, 2024	SELL	$262.75 - $319.31 $1.02 Million - $1.24 Million	-3,886 Reduced 5.1%	72,282 $22.6 Million
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $56,193 - $67,833	-209 Reduced 0.27%	76,168 $21.7 Million
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $20,967 - $23,653	82 Added 0.11%	76,377 $22 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $24,051 - $29,860	110 Added 0.14%	76,295 $20.5 Million
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $368,330 - $435,543	1,719 Added 2.31%	76,185 $16.9 Million
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $12,870 - $15,686	-57 Reduced 0.08%	74,466 $18 Million
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $131,463 - $167,039	-574 Reduced 0.76%	74,523 $19.6 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $24,241 - $27,340	-108 Reduced 0.14%	75,097 $16.9 Million
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $2,307 - $2,567	-10 Reduced 0.01%	75,205 $18.3 Million
Q1 2022 Apr 21, 2022	BUY	$219.27 - $242.57 $111,827 - $123,710	510 Added 0.68%	75,215 $18.2 Million
Q4 2021 Feb 01, 2022	BUY	$198.88 - $227.6 $204,249 - $233,745	1,027 Added 1.39%	74,705 $16.8 Million
Q3 2021 Oct 25, 2021	BUY	$212.27 - $248.7 $969,437 - $1.14 Million	4,567 Added 6.61%	73,678 $15.7 Million
Q2 2021 Jul 22, 2021	BUY	$233.58 - $259.14 $76,614 - $84,997	328 Added 0.48%	69,111 $16.8 Million
Q1 2021 May 04, 2021	SELL	$221.91 - $258.6 $114,283 - $133,179	-515 Reduced 0.74%	68,783 $17.1 Million
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $226,117 - $269,265	1,045 Added 1.53%	69,298 $15.9 Million
Q3 2020 Oct 26, 2020	SELL	$234.65 - $260.95 $209,073 - $232,506	-891 Reduced 1.29%	68,253 $17.3 Million
Q2 2020 Jul 27, 2020	SELL	$197.81 - $242.74 $116,510 - $142,973	-589 Reduced 0.84%	69,144 $16.3 Million
Q1 2020 Apr 24, 2020	BUY	$182.24 - $241.7 $20,046 - $26,587	110 Added 0.16%	69,733 $14.1 Million
Q4 2019 Jan 16, 2020	BUY	$189.21 - $243.2 $24,597 - $31,616	130 Added 0.19%	69,623 $16.8 Million
Q3 2019 Oct 16, 2019	BUY	$174.11 - $208.62 $95,064 - $113,906	546 Added 0.79%	69,493 $13.4 Million
Q2 2019 Jul 25, 2019	SELL	$166.7 - $195.41 $220,043 - $257,941	-1,320 Reduced 1.88%	68,947 $12.7 Million
Q1 2019 Apr 15, 2019	SELL	$180.87 - $203.88 $4.07 Million - $4.59 Million	-22,502 Reduced 24.26%	70,267 $13.3 Million
Q4 2018 Jan 16, 2019	BUY	$178.4 - $208.25 $214,793 - $250,733	1,204 Added 1.31%	92,769 $18.1 Million
Q3 2018 Oct 19, 2018	SELL	$185.29 - $208.89 $14,082 - $15,875	-76 Reduced 0.08%	91,565 $19 Million
Q2 2018 Jul 27, 2018	BUY	$166.05 - $186.51 $483,703 - $543,303	2,913 Added 3.28%	91,641 $16.9 Million
Q1 2018 Apr 25, 2018	BUY	$169.43 - $198.0 $724,143 - $846,252	4,274 Added 5.06%	88,728 $15.1 Million
Q4 2017 Feb 01, 2018	BUY	$168.79 - $188.59 $228,710 - $255,539	1,355 Added 1.63%	84,454 $0
Q3 2017 Nov 02, 2017	BUY	$167.29 - $191.0 $437,463 - $499,465	2,615 Added 3.25%	83,099 $15.5 Million
Q3 2017 Oct 26, 2017	BUY	$167.29 - $191.0 $13.5 Million - $15.4 Million	80,484	80,484 $15 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Asset Management, LLC with notifications on news.

Account

Palisade Asset Management, LLC Amgen Inc Transaction History